Despite the Covid-19 pandemic, rising unemployment, and 2020’s other woes, healthcare technology firms continue to go public. So far, six health tech firms have already gone public in 2020.
Amplified Sciences emerged as the winner of the diagnostics track for the MedCity INVEST conference's Pitch Perfect contest with PanCystPro, the test it is developing to address the problems encountered when determining whether pancreatic cysts are cancerous.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The company is hoping to close its seed funding round in the next six months and aims to be in a position to seek regulatory approval for its lead asset, PLX888, in acute alcoholic hepatitis in 2023.
Patient engagement platform Luma Health was designed to help patients schedule appointment with the doctor without having to wait months. With Covid-19, the startup's vision has expanded.
Healthcare startups across health services, health IT, medical devices, biopharma and diagnostics tracks took part in the week-long competition at the conference July 20-24. Here are the winners for the five tracks.
In a panel discussion during MedCity INVEST Thursday, investors discussed how the Covid-19 pandemic and social distancing requirements have impacted the way they interact with companies.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
Today marks the last day of INVEST. Check our events page for agenda updates for our other virtual conferences this year including INVEST Digital Health, INVEST Population Health, INVEST Precision Medicine, and our collaboration with HLTH: ENGAGE at HLTH.
Scenario planning and lessons learned from past downturns can help leadership teams guide their startups through an uncertain economy.
MedCity spoke with Evidation and BrightInsight, two startups that have recently announced funding rounds, amid a Covid-19 pandemic worsening in the U.S.
Several states have enacted changes to make it easier for patients to access mental health services via telehealth during the pandemic. Here's a summary of what has changed so far.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
How can companies strike the right balance between growing and scaling their business? A new report shows how an HR team can help.
Medical device startups take center stage today including: Actuated Medical, emocha Health, HT BioImaging, iNNOGING Medical, and Sense Neuro. Register now!
Executives with Kaiser Permanente, Houston Methodist, Providence St. Joseph Health and Highmark Health shared their thoughts on the future of digital health and how they used technology to care for their patients at the start of the Covid-19 pandemic.
"Everybody's an infectious disease company now," ARCH Venture Partners Managing Director Bob Nelsen said. By contrast, a report last year showed a huge decline in venture capital investment in the infectious disease space.
In an interview, TriNet’s Vice President of Life Sciences, Maria Abouseif, talked about the role Professional Employer Organizations play in helping life science companies navigate the COVID-19 public health crisis.